Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment using selective 5-HT2A inverse agonists

Methods of treatment using selective 5-HT2A inverse agonists

US Patent 9765053 · Granted Sep 19, 2017

Estimated economic value: $54,916,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2020
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2020
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2018
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2018
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2017
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2017
Azacyclic compounds2016
Azacyclic compounds2016
Azacyclic compounds2016
Azacyclic compounds2016
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2015
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodeg2015